IP Library Granted Patent US 11,602,348
Granted Patent B2
US 11,602,348 · App. 17/481,592 · Granted Mar 14, 2023

Bridging peripheral nerve gaps with conduits for enhanced nerve regeneration

Inventors: Alexander Woods (Oxford, GB); Robyn Plowright (Bicester, GB); Friedrich Vollrath (Oxford, GB)
Assignee: NEWROTEX LIMITED
A61B17/1128A61L31/044A61L31/16A61L2430/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,602,348
App. No.
17/481,592
Granted
Mar 14, 2023
Kind
B2
Abstract

Disclosed herein are compositions comprising containers and silk elements. Disclosed herein are methods of regenerating an at least partially severed nerve cell. Disclosed herein are compositions for regenerating an at least partially severed nerve cell.

Claims (41)

1. A medical device comprising a sheath configured to encourage a regrowth of at least a portion of a nerve cell in vivo within said sheath, wherein said sheath:

(a) is at least in part flexible, wherein said sheath being at least in part flexible is created by a crosslinking of said sheath, wherein said at least in part flexible comprises an ability to bend said sheath into less than about a 90° angle between a proximal end and a distal end of said sheath, wherein bending said sheath comprises bending without breaking said sheath, without kinking said sheath, while maintaining a patency of said sheath, while maintaining a patency of a lumen of said sheath, or any combination thereof, and wherein said sheath comprises a silk,

(b) is configured to at least partially allow an influx of nutrients, an outflow of waste, or both, through openings in said sheath,

(c) comprises an entrance and an exit, wherein said sheath is configured to allow at least a portion of a nerve cell to enter and exit said sheath through said entrance and said exit,

(d) comprises an interior and an exterior, and

(e) comprises at least partially in said interior an element, wherein said element comprises a fiber, a filament, or a combination thereof, spanning at least a portion of a length of said sheath.

2. The medical device of claim 1 , wherein said element spans a majority of said length of said sheath.

3. The medical device of claim 1 , wherein said sheath is configured to encourage, guide, orientate, support, or any combination thereof, said in vivo regrowth of said at least a portion of said nerve cell.

4. The medical device of claim 1 , wherein after a force that bends said sheath ceases to be applied, said sheath returns at least in part to a pre-bend shape.

5. The medical device of claim 1 , wherein said sheath further comprises a protein, a collagen, a gelatin, a silicone, a polymer, a polyester, a hydrophilic material, a polyol, a hybrid composition, an isolated tissue, an isolated tissue product, a decellularized nerve conduit, a carbohydrate, a biomimetic material, a silk composite, or any combination thereof.

6. The medical device of claim 5 , comprising said collagen, wherein said collagen comprises a type I collagen, a type II collagen, a type III collagen, a type V collagen, a type X collagen, a salt of any of these, or any combination thereof.

7. The medical device of claim 5 , comprising said polyester, wherein said polyester comprises a polyglycolic acid.

8. The medical device of claim 1 , wherein said element comprises a plurality of silk elements.

9. The medical device of claim 8 , wherein at least some of said silk elements in said plurality are at least partially covered in a hydrophilic substance.

10. The medical device of claim 9 , wherein said hydrophilic substance comprises a substance which when contacted with water at least partially forms a gel.

11. The medical device of claim 10 , wherein said gel comprises a hydrogel.

12. The medical device of claim 1 , wherein said openings comprise a plurality of pores.

13. The medical device of claim 12 , wherein at least one pore of said plurality of pores traverses said interior of said sheath through to said exterior of said sheath.

14. The medical device of claim 12 , wherein at least one pore of said plurality of pores has a maximum diameter of about 200 μm.

15. The medical device of claim 12 , wherein said plurality of pores are distributed substantially throughout said length of said sheath.

16. The medical device of claim 12 , wherein said plurality of pores are substantially uniformly distributed throughout said length of said sheath.

17. The medical device of claim 1 , wherein said sheath is in a form of a tube.

18. The medical device of claim 1 , wherein said sheath comprises a smooth internal wall.

19. The medical device of claim 1 , wherein said sheath comprises a smooth exterior wall.

20. A medical device comprising a sheath configured to encourage a regrowth of at least a portion of a nerve cell in vivo within said sheath, wherein said sheath:

(a) is at least in part flexible,

(b) is configured to at least partially allow an influx of nutrients, an outflow of waste, or both, through a plurality of pores in said sheath,

(c) comprises an entrance and an exit, wherein said sheath is configured to allow at least a portion of a nerve cell to enter and exit said sheath through said entrance and said exit,

(d) comprises an interior and an exterior,

(e) comprises a collagen; and

(f) comprises at least partially in said interior at least two bundles comprising a plurality of silk elements spanning at least a portion of a length of said sheath, wherein each individual silk element in said plurality of silk elements is wrapped in a first hydrophilic coating, wherein at least two of said at least two bundles comprising said plurality of silk elements are wrapped in a second hydrophilic coating, and wherein said silk elements comprise a fiber, a filament, or a combination thereof.

21. The medical device of claim 20 , wherein said first hydrophilic coating of each individual silk element comprises an at least partial coating of hyaluronic acid.

22. The medical device of claim 20 , wherein said second hydrophilic coating of said at least two bundles comprises an at least partial coating of hyaluronic acid.

23. The medical device of claim 22 , further comprising a bundle of said at least two bundles, wherein said bundle of said at least two bundles is wrapped in a third hydrophilic coating of said bundle of said at least two bundles.

24. A medical device comprising a sheath configured to encourage a regrowth of at least a portion of a nerve cell in vivo within said sheath, wherein said sheath:

(a) is at least in part flexible,

(b) is configured to at least partially allow an influx of nutrients, an outflow of waste, or both, through a plurality of pores in said sheath,

(c) comprises an entrance and an exit, wherein said sheath is configured to allow at least a portion of a nerve cell to enter and exit said sheath through said entrance and said exit,

(d) comprises an interior and an exterior,

(e) comprises a polyglycolic acid (PGA); and

(f) comprises at least partially in said interior at least two bundles comprising a plurality of silk elements spanning at least a portion of a length of said sheath, wherein each individual silk element in said plurality of silk elements is wrapped in a first hydrophilic coating, wherein at least two of said at least two bundles comprising said plurality of silk elements are wrapped in a second hydrophilic coating, and wherein said silk elements comprise a fiber, a filament, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: WOODS, ALEXANDER; PLOWRIGHT, ROBYN; VOLLRATH, FRIEDRICH
To: NEWROTEX LIMITED
Reel/Frame 057660/0200 →
Continuity (4)
Continuation PCTGB2021051746 · Jul 8, 2021
Provisional Application 63093866 · Oct 20, 2020
Provisional Application 63049289 · Jul 8, 2020
Related Publication 20220031328A1 · Feb 3, 2022
Cited By (2)
US 12,471,923 US 12,544,073